Catch up on any of the neurology headlines you may have missed in October 2026, compiled into 1 place by the NeurologyLive® team.
|Podcasts|August 26, 2022
Episode 71: Pediatric Sleep and School Start Times
Author(s)Matt Hoffman
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Chris Winter, MD. [LISTEN TIME: 31 minutes]
Advertisement
Episode 71 of the NeurologyLive®
The Mind Moments® podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 71, "Pediatric Sleep and School Start Times," features an exclusive interview with Chris Winter, MD, owner of Charlottesville Neurology and Sleep Medicine clinic and CNSM Consulting, and an author of several books on sleep. He shared his perspective on the state of pediatric sleep disorders, how the current system of schooling affects children's sleep, and the trends that are occurring in sleep research.
This episode is brought to you by Medical World News. Check out new episodes of a variety of shows, airing every single day, only on
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Passage Bio Doses First Patient in Frontotemporal Dementia Gene Therapy Trial BLA Application to Be Submitted for ALS Agent NurOwn Following Phase 3 Statistical Corrections Jazz Initiates Trial Assessing Cannabidiol in Epilepsy With Myoclonic-Atonic Seizures
EPISODE BREAKDOWN
1:15 – Current conversations around school start times and sleep
5:25 – The role of virtual schooling in helping sleep
9:00 – Education about sleep for children, parents, and professionals
13:15 – The current trends in sleep-focused behaviors
14:30 – The prevalence and awareness of pediatric sleep disorders
16:35 – Neurology News Minute
19:30 – Improving sleep evaluation in daily clinical practice
24:00 – The trends in sleep medicine
26:30 – Leveraging the inherent attractiveness of sleep conversations
27:00 – Tips for the clinical community and self-advocacy
Advertisement
Related to this article
At a NeurologyLive Clinical Forum in Phoenix, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how a lack of adult neuro-oncology infrastructure is shaping how NF1-associated plexiform neurofibromas get recognized, referred, and treated.
The FDA granted fast track designation to FRP-003, an investigational oral botanical drug candidate for Long COVID, ahead of a planned phase 2 trial evaluating fatigue in approximately 220 adults.
GV101 receives FDA fast track designation for the treatment of Friedreich ataxia, with a phase 2 trial planned to begin enrollment in late 2026.
In honor of Veterans Day, Clayton Mucha, DO, neurorehabilitation physiatrist at Burke Rehabilitation in New York, discusses the lasting effects of traumatic brain injury in military personnel.
At a NeurologyLive Clinical Forum in New York, Mary Ann Piccone, MD, of Holy Name Medical Center, led a wide-ranging discussion among MS specialists on the limits of current high-efficacy therapies, the pipeline of emerging agents, and the gap between physician and patient treatment priorities.
Odinachi Oguh, MD, movement disorder specialist at the Cleveland Clinic Lou Ruvo Center for Brain Health, shares clinical perspectives on biomarkers, aging, non-motor symptoms, and prodromal disease from the 2026 MDS Congress.
A study of deceased former NFL players estimated that nearly 75% had CTE neuropathology, while a phase 3 trial is evaluating whether F-18 FNT-PET imaging could help identify disease-associated patterns in living patients.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
FDA Approves Factor XIa Inhibitor Asundexian for Secondary Stroke Prevention
3
GV101 Gains FDA Fast Track Status for Friedreich Ataxia Ahead of Phase 2 Trial
4
New York Forum Tackles Unmet Needs in Multiple Sclerosis Care
5